Supernus Pharmaceuticals
SUPN
$28.74
Share price
-0.79%
Change (1 day)
-17.27%
Change (1 year)
Categories
Market capitalization of Supernus Pharmaceuticals (SUPN)
Market cap: $1.57 Billion
As of May 2024 Supernus Pharmaceuticals has a market cap of $1.57 Billion. This makes Supernus Pharmaceuticals the world's 4541th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Supernus Pharmaceuticals from 2012 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $1.57 B | -0.07% |
| 2023 | $1.58 B | -18% |
| 2022 | $1.92 B | 24.34% |
| 2021 | $1.55 B | 16.58% |
| 2020 | $1.33 B | 6.75% |
| 2019 | $1.24 B | -28.3% |
| 2018 | $1.73 B | -14.92% |
| 2017 | $2.04 B | 63.31% |
| 2016 | $1.25 B | 89.92% |
| 2015 | $0.65 B | 84.65% |
| 2014 | $0.35 B | 18.31% |
| 2013 | $0.30 B | 37.31% |
| 2012 | $0.21 B |
End of Day market cap according to different sources
On May 15th, 2024 the market cap of Supernus Pharmaceuticals was reported to be:
$1.61 Billion
$1.61 Billion
$1.57 Billion
$1.58 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $367.42 B | 23,155.50% | 🇺🇸 USA |
 Abbott Laboratories ABT | $181.94 B | 11,415.97% | 🇺🇸 USA |
 Eli Lilly LLY | $747.98 B | 47,242.15% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $90.30 B | 5,615.79% | 🇺🇸 USA |
 Zogenix ZGNX | $1.50 B | -5.05% | 🇺🇸 USA |
 United Therapeutics UTHR | $12.09 B | 665.73% | 🇺🇸 USA |